CurrentHealth NetPolicy CP.MP.210

Repair of Nasal Valve Compromise

Medical necessity guidelines for surgical and procedural repair of nasal valve compromise for members of Health Net/Centene-affiliated health plans, including which procedures are considered medically necessary versus not medically necessary.

Policy Summary

PayerHealth Net

PolicyRepair of Nasal Valve Compromise

Policy CodePolicy CP.MP.210

Change TypeNo material changes

Effective Date

Next Review Date

Key ActionDocument clinical findings, response to the Cottle maneuver or lateralization tests, and prior conservative therapy trials when requesting coverage.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

I. and II.Policy sections

1Supporting CPT codes

2Non-supporting CPT codes

Coverage Criteria for Repair of Nasal Valve Compromise

Medically Necessary Criteria

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Main criteria: Member meets all A–D criteria

A. Clinical findings: One or more of the following: internal valve collapse or compromise of the upper lateral cartilage; external nasal valve compromise due to collapse of the lower lateral cartilage.

Clinical findings should be supported by physical examination.

B. Symptom response to maneuvers: Complaints of obstructed breathing that resolve with the Cottle maneuver or with lateralization of the upper lateral cartilage from inside the nose using an object (e.g., cotton swab, nasal speculum) or demonstrated improvement with outpatient trials of external stents or nasal dilators (e.g., Breathe Right nasal strips, Max-Air Nose Cones, Sinus Cones).

C. Exclusion of other causes: Other causes of obstructed breathing have been ruled out (examples: sinusitis, allergic or nonallergic rhinitis, nasal polyps, adenoid hypertrophy, nasopharyngeal masses, septal deviation, turbinate hypertrophy).

D. Conservative therapy trial: Symptoms persist despite conservative treatment such as nasal cones, external nasal dilator adhesive strips, or a six‑week trial of nasal steroids.

General policy applicability

Policy scope and application statements:

Policy governance: This clinical policy is a guide to medical necessity developed by experienced clinicians after review of peer‑reviewed literature and other authoritative sources; it does not constitute a contract or guarantee of payment. Providers must exercise professional medical judgment and consult enrollee coverage documents and applicable state Medicaid or Medicare NCDs/LCDs when applying this policy.

Coverage decisions are subject to all terms, conditions, exclusions and limitations of the enrollee's coverage documents and to applicable law and plan administrative policies.

This clinical policy states that certain procedures for repair of nasal valve compromise are not medically necessary because safety and efficacy have not been established. Specifically, the policy identifies radiofrequency ablation (VivAer®), absorbable nasal implants (Latera®), and nasal valve suspension surgery as procedures considered not medically necessary for repairing nasal valve compromise. These exclusions are listed in Section II of the policy and reflect the plan’s assessment of currently available evidence regarding those technologies.

The following procedures are explicitly listed as not medically necessary for the repair of nasal valve compromise: VivAer® (radiofrequency ablation), absorbable nasal implants (Latera®), and nasal valve suspension surgery. The policy cites insufficient established safety and efficacy to support coverage of these specific interventions.

This document is intended to provide guidance used to evaluate medical necessity and to assist in making coverage decisions, but it does not itself create the legal or contractual definition of medical necessity. Providers are expected to exercise professional medical judgment and to consult enrollee coverage documents and applicable state or federal requirements when applying this guidance.

Coding — Relevant CPT and Other Codes

CPT Codes That Support Coverage CriteriaCPTCovered

30465

Repair of nasal vestibular stenosis (e.g., spreader grafting, lateral nasal wall reconstruction)

CPT Codes That Do Not Support Coverage CriteriaCPTNot Covered

30468	Repair of nasal valve collapse with subcutaneous/submucosal lateral wall implant(s).
30469	Repair of nasal valve collapse with low energy, temperature-controlled (i.e., radiofrequency) subcutaneous/submucosal remodeling

Referenced codes (document refers to applicable coverage determinations)mixed

affected codes

placeholder text in this part of the document instructing review of applicable NCDs/LCDs and plan requirements

Provider Actions, Authorization, and Documentation Requirements

Prior Authorization

Prior Authorization / Code Implications

Prior authorization is required for procedures represented by CPT 30465. Coverage is contingent on documentation that all required clinical criteria (Section I.A–I.D) are met. Verify applicable CPT coding guidance prior to claim submission.

Affected code: CPT 30465 (supports coverage)
Codes that do not support coverage: CPT 30468, CPT 30469

Prior Authorization

Prior Authorization and Coverage Alignment

Providers must review applicable National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) prior to applying this policy. Prior authorization requirements and coverage decisions remain subject to the member's contract terms, exclusions, and limitations.

Prior authorization applies where the Health Plan requires it
Coverage determinations do not guarantee payment and are subject to plan contract terms

Documentation Required

Conservative Therapy Requirement

Conservative therapy must be attempted and documented before surgical intervention. Examples include use of nasal cones, external nasal dilator adhesive strips, or a six-week trial of nasal steroids.

Document trials of outpatient nocturnal external stents (e.g., Breathe Right® nasal strips) or nasal dilators (e.g., Max-Air Nose Cones®, Sinus Cones®)
Document duration and response to a six-week trial of nasal steroids when used

Documentation Required

Required Clinical Documentation

Document clinical findings supporting nasal valve compromise and response to diagnostic maneuvers. Providers should record physical exam findings (e.g., internal or external valve collapse), results of the Cottle maneuver or lateralization tests, NOSE score when available, and that other causes of obstruction have been ruled out.

Document location (unilateral vs bilateral) and duration of symptoms
Document exclusion of other causes (sinusitis, allergic/nonallergic rhinitis, nasal polyps, septal deviation, turbinate hypertrophy)
Document specific diagnostic tests used and their results (e.g., NOSE score, rhinomanometry, anterior rhinoscopy)

Denial Risk

Denial Risk and Applicability

Procedures that do not meet the specified criteria in Section I or are listed as not medically necessary in Section II (e.g., VivAer® radiofrequency ablation, absorbable implants such as Latera®, nasal valve suspension) are at risk for denial. Providers are expected to exercise professional medical judgment; this policy is guidance and does not guarantee payment.

Not medically necessary procedures: CPT 30468, CPT 30469
Coverage decisions are subject to enrollee's contract terms and applicable laws

Background

Nasal valve compromise (NVC), also called nasal valve collapse, is a narrowing of the nasal passage that can cause obstructed breathing. Causes include structural weakness of the internal or external nasal valve (upper lateral cartilage or lower lateral cartilage), prior nasal surgery, trauma, chronic inflammation, congenital defects, or age-related changes. NVC may present as unilateral or bilateral nasal obstruction and is assessed by history, physical examination, maneuvers such as the Cottle test or manual lateralization, and adjunctive objective measures when indicated.

Definitions and Procedure Summaries

Internal nasal valve compromise

DefinitionCollapse or compromise of the upper lateral cartilage leading to obstruction of the internal nasal valve area.

Clinical finding (policy)Listed as a qualifying clinical finding for medically necessary repair of nasal valve compromise (Section I.A.1).

Relevant diagnostic maneuversImprovement with Cottle maneuver or lateralization of the upper lateral cartilage helps demonstrate clinical significance.

External nasal valve compromise

DefinitionCollapse of the lower lateral cartilage (alar rim) resulting in external nasal valve dysfunction.

Clinical finding (policy)Listed as a qualifying clinical finding for medically necessary repair of nasal valve compromise (Section I.A.2).

Related considerationsExternal valve compromise may present with obstructed breathing and should be differentiated from other causes such as septal deviation or turbinate hypertrophy.

VivAer (Aerin) procedure

ProcedureOffice-based low-dose radiofrequency (RF) procedure that remodels intranasal soft tissues to reduce nasal valve collapse (Aerin VivAer system).

Evidence summaryHayes' review cites minimal support; studies are limited in quality and do not clearly demonstrate objective improvements in nasal patency.

Coverage stanceSpecifically listed as not medically necessary for repair of nasal valve compromise by the Health Plan due to insufficient established safety and efficacy (Section II.A).

Latera (absorbable implant)

Device descriptionAbsorbable PLLA/PDLA nasal implant placed endonasally via a 16-gauge cannula to support lateral nasal wall cartilage; envelope by fibrous tissue and absorbed over ~12–18 months with replacement by fibrous collagen matrix.

Clinical evidenceEvidence is generally very poor quality with limited controlled studies; minimal support for clinical performance compared with other technologies per Hayes review.

Coverage stanceListed as not medically necessary for repair of nasal valve compromise by the Health Plan because safety and efficacy have not been established (Section II.B).

Health Plan

DefinitionA health plan that has adopted this clinical policy and that is operated or administered, in whole or in part, by Centene Management Company, LLC, or affiliates.

Policy roleThis clinical policy is a guide to medical necessity used to assist coverage decisions and administration of benefits; it does not constitute a contract or guarantee of payment.

Jurisdictional noteWhere state Medicaid provisions conflict with this clinical policy, state Medicaid coverage provisions take precedence.